R97.21
Billable codeRising PSA following treatment for malignant neoplasm of prostate
The ICD-10 code for rising psa following treatment for malignant neoplasm of prostate is R97.21.
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- R97.20Elevated prostate specific antigen [PSA]
- R97.21Rising PSA following treatment for malignant neoplasm of prostate
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 79093Approximate match
Associated MS-DRGs
R97.21 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.